We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement

AMSBIO Expands US Operations

News  
Published: April 23, 2014
 

Want a FREE PDF version of this news story?

Complete the form below and we will email you a PDF version of "AMSBIO Expands US Operations"

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy
Listen with
Speechify
0:00
Register for free to listen to this article
Thank you. Listen to this article using the player above. ✖
Read time:
 

AMSBIO has announced the opening of a new North American headquarters with executive management facilities in Cambridge, MA for its US subsidiary - AMSBIO LLC.

Commenting on this strategic move, Alex Sim (President, AMSBIO) said “The US is the single largest market for our stem cell and regenerative medicine, glycobiology enzymes / substrates and tissue derived products. Drawing upon our in-depth expertise in extracellular matrices we are able to also provide elegant solutions for studying cell motility, migration, invasion and proliferation”.

He added “Our North American customer base has been growing strongly over recent years. From the new East Coast facility we will provide local informed service and support as well as next day delivery of a comprehensive range of enabling technology products to help improve the productivity of our US customers”.

Advertisement
Advertisement
Advertisement
Decoratvive background images
Never miss a story
with the Breaking Science News daily newsletter